Purpose: To objectively compare residual colonic fluid volume and attenuation of oral sulfate solution (OSS) with four different established cathartic regimens using an automated volumetric software tool at CT colonography (CTC). Methods: This HIPAA-compliant study had institutional review board approval. Volumetric analysis of residual contrast-tagged colonic fluid was performed on CTC studies in 263 adults (mean age 60.1 years; 137M/126F) using an automated volumetric software tool. Twentythree patients receiving 177 mL OSS (SUPREP; singlebottle purgation) were compared with 60 patients each receiving 45 mL sodium phosphate (NaP), 90 mL NaP (29 NaP), 592 mL (two bottles) magnesium citrate (MgC), and 4,000 mL polyethylene glycol (PEG). All patients received oral contrast cleansing after catharsis. Data were analyzed with unpaired t test with Welch correction and F test. Results: The mean volume of residual colonic fluid was less with OSS (125 ± 60 mL) than for established cathartic agents: 29 NaP (206 ± 125 mL, P < 0.0001), MgC (184 ± 125 mL, P < 0.01), PEG (166 ± 114 mL, P < 0.05), and NaP (165 ± 135 mL, P = 0.067). Variance of volumes was also significantly lower for OSS (range 28-251 mL) than for established agents (range 4-853 mL) (all P < 0.01). Mean fluid attenuation was higher with OSS (956 ± 168 HU) than for established agents (all P < 0.05): 29 NaP (455 ± 191 HU), MgC (691 ± 154 HU), NaP (779 ± 127 HU), and PEG (843 ± 193 HU).
to be effective in colon cleansing at both OC and CTC [16, 17] , but are now seldom used given the rare but finite risk of acute phosphate nephropathy [18] . Magnesium citrate (MgC) is now considered a front-line laxative for bowel preparation for CTC [19] . In general, these lowvolume regimens are believed to be superior to highvolume regimens such as polyethylene glycol (PEG) with regard to residual fluid retention, as well as patient compliance and preference [16, 17, 20, 21] . However, identification of a cathartic agent that further reduces residual fluid while at the same time retaining high patient compliance would be desirable to further improve diagnostic quality.
A new formulation of low-volume oral sulfate solution (OSS; SUPREP) has been recently developed and employed for optical colonoscopy [22] . Sulfate is a poorly absorbed anion and OSS does not alter electrolyte balance [22] . The recommended OSS regimen for OC consists of two 177-mL bottles in a split dose. Together, both administrations provide purgation and result in an adequately cleansed colon, suitable for OC. A recent randomized OC clinical study yielded excellent preparation results using the split-dose OSS regimen with two bottles [23] . We aimed to assess the efficacy of a single bottle of OSS for colonic purgation. We hypothesized that a single bottle of OSS for purgation should suffice for CTC bowel preparation because the ionic-iodinated oral contrast (sodium diatrizoate/diatrizoate meglumine) acts as an additional mild cathartic or cleansing agent. If this approach proves to be effective for CTC, it could reduce costs and increase patient compliance.
However, assessment of the efficacy of cathartic agents is often cumbersome and large study cohorts are needed [19, 21, 24] . We now have access to a fully automated volumetric CTC software tool that provides exact quantification of the total volume and mean attenuation of the residual colonic fluid. If effective, the use of this automated volumetric quality assessment (QA) software may standardize, simplify, and expedite the process of assuring a standard of quality in CTC. The purpose of this study was to perform an objective comparison of volume and attenuation of residual colonic fluid with four different established cathartic regimens to a single bottle of newer oral sulfate solution (OSS; SU-PREP) regimen using an automated volumetric software tool at CTC.
Methods

Study design
This retrospective study complied with the Health Insurance and Portability and Accountability Act and was approved by our institutional review board; the need for informed consent was waived. We identified at total of 275 patients that underwent CTC evaluation using a variety of cathartic regimens. Patients were only included in the final analyzes if the entire colon could be processed with the CTC software in terms of calculating the total luminal fluid volume. Cases were excluded when the automated tool did not capture all segments of luminal fluid. Twelve cases (4.4%) were excluded due to incomplete segmentation of luminal fluid, typically related to decreased attenuation from inadequate tagging. In a total of 263 cases (95.6%), the CTC software successfully calculated the total residual fluid. We identified 60 consecutive patients that received single-dose (45 mL) NaP, 60 that received double-dose (90 mL) NaP (29 NaP), 60 that received double-dose (592 mL) MgC, and 60 that received 4 L PEG. These four established cathartic regimens were compared with 23 consecutive patients who received a single bottle (177 mL) of oral sulfate solution (OSS; SUPREP, Braintree Laboratories) for purgation, which were supplied by the company as free samples (see different specific cathartic regimes below). All patients underwent oral contrast tagging/cleansing after the cathartic regimen. The tagging regimen (see below) was identical between the all groups, with the exception of the double-dose NaP group, for which the oral contrast volume was doubled (split-dose regimen). Patients without oral tagging were excluded.
Mean patient age was 60.1 years (range 45-93 years), with 126 women and 137 men. Mean patient body mass index (BMI) was 28.7 kg/m 2 (range 16.6-52.1 kg/m 2 ). The mean age and sex distribution were similar for the five study groups (Table 1) .
Cathartic regimes
Starting the day before the scheduled CTC examination, patients were restricted to a clear liquid diet and received two 5-mg bisacodyl tablets, which were taken before 11:00 a.m.. Three to six hours after the bisacodyl tablets, patients ingested the different cathartic agents. The five regimens were as follows:
Single-dose NaP regimen consisted of ingestion of 45 mL of NaP solution (Phospho-soda, Fleet laboratories, Lynchburg, VA). Double-dose NaP regimen consisted of ingestion 2 9 45 mL phosphate solution (Phospho-soda, Fleet laboratories) divided into two doses separated by 3 h. The evening before CTC all patient groups were also given 250 mL of (2%) barium sulfate (Readi-Cat 2; E-Z-EM, Lake Success, NY) to tag residual solid stool and 60 mL of sodium diatrizoate/diatrizoate meglumine (MD-Gastroview; Mallinckrodt, Hazelwood, MO) to tag residual fluid and provide supplementary tagging. This oral contrast regimen was repeated on the morning of the examination for the double-dose NaP group only.
Colonic distention and CT acquisition protocol
Automated CO 2 delivery (PROTOCO 2 L, Bracco Diagnostics) was used to achieve colonic distention. No spasmolytics were employed. After equilibrium intraluminal pressure was achieved, supine and prone CT image acquisition was performed on 4-64 multi-detector CT scanners (GE Healthcare, Waukesha, WI). Acquisition parameters consisted of 1.25-2.50 mm collimation, 1-to 2-mm reconstruction interval, 120 kV p , and tube current modulation (noise index set at 50, 30-300 mA range) or 100 mA.
Data collection and analysis
The total volume and mean attenuation of the residual colonic fluid for each patient were derived using automated quality assessment (QA) software available on a beta version of our CTC software (V3D Colon; Viatronix, Stony Brook, NY). Proper processing required correct centerline generation and colonic segmentation. However, areas of complete collapse were allowed as long as these segments contained no or negligible luminal fluid on visual inspection. In this situation, the software automatically crossed the collapsed segment. The colon segmentation algorithm detects the gas-filled luminal cavity by initial thresholding. After visual confirmation and approval of correct segmentation, the QA software uses a region growing technique to delineate all tagged fluid regions connected to the gas-filled lumen by probing for seed pixels greater than 200 HU along the gravitational direction with defined spatial range constraints. In a final step, the partial volume layer that forms between air and tagged fluid is determined. The processed total colonic lumen consist of gas, tagged fluid, and partial volume layer regions. A median filtering technique is applied to the extracted regions to remove morphological irregularity caused by image noise and artifacts. Voxels in the colon lumen region that are less than 200 HU are labeled as air. Voxels in the colon lumen region that are greater than or equal to 200 HU are labeled as tagged fluid. Gas volume, fluid volume, and average fluid attenuation values are calculated by counting the voxels with selected labels.
We recorded the provided luminal fluid volume and its average attenuation (CT attenuation number in HU). The efficiency of the automated fluid detection was verified online on axial two-dimensional CTC image review with and without digital subtraction of the tagged fluid (electronic cleansing). This step confirmed that all residual tagged colonic luminal fluid was captured by the automated volumetric tool.
Statistical analyses
Continuous data were expressed as means with standard deviations. Unpaired t test with the Welch correction was used to compare fluid volumes and fluid densities between established agents and OSS regime. Fisher's exact test was performed to compare the total numbers of optimal vs. suboptimal bowel preparations regarding the total volume of residual fluid. We defined total residual colonic fluid volumes below 200 mL as excellent based on subjective image review. F test was used to compare variances of residual fluid volumes between established agents and OSS. Pearson correlation was obtained between volume and attenuation of residual colonic fluid. Statistical computations were obtained with MedCalc Statistical Software version 12.7.5 (MedCalc Software bvba, Ostend, Belgium). A P value of less than 0.05 indicated a statistically significant difference.
Results
No significant complications were encountered with any of the CTC bowel preparation regimens in the 263 patients. The automated volumetric CTC software tool successfully calculated the mean volume (175 ± 118 mL, range 4-853 mL) and the attenuation (715 ± 231 HU, range 230-1365 HU) of the residual colonic fluid in all 263 patients. The automated calculation time for volume and attenuation ranged from 5 to 15 s. Importantly, not only large and obvious fluid residues were captured, but also tiny pools of luminal fluid. This was visualized and verified online on axial two-dimensional CTC image review using the built-in digital subtraction tool (Fig. 1) .
A statistically significant difference (P < 0.001) was observed for the volume of residual colonic fluid between the pooled established cathartic regimens (i.e., 29 NaP, MgC, NaP, and PEG) (180 ± 121 mL, n = 240) and the OSS regime (125 ± 60 mL, n = 23) ( Fig. 2A) . Residual fluid volumes <200 mL were recorded in 66.3% (159/ 240 examinations) following the use of established agents and in 87.0% (20/23 examinations) following OSS regime (P = 0.06). The variance of the observed volumes was also significantly higher for the average of the established regimens (range 4-853 mL) as compared to OSS (range 28-251) (P < 0.001). The higher variance among the 240 patients receiving established cathartic agents is illustrated by 11 outlier cases (4.6%) (see Fig. 2A , indicated as individual points) with high residual fluid volumes ranging from 440 to 853 mL.
Likewise, the mean attenuation of the residual fluid was significantly higher (P < 0.0001) in the OSS group (956 ± 167 HU) compared with the pooled established cathartic regimens (692 ± 223 HU) (Fig. 2B) . The impact of different volumes and densities of the residual fluid on visual assessment of two-dimensional CTC is exemplified in Fig. 3 .
Comparison of the individual established cathartic regimens (29 NaP, MgC, NaP, and PEG) vs. SUPRPEP further substantiated the overall superiority of the OSS regimen (Fig. 4) . Mean residual fluid volume was smallest when using the OSS regimen (125 ± 60 mL) and significantly lower than with 29 NaP regimen (206 ± 125 mL), MgC regimen (184 ± 125 mL) or PEG regimen (166 ± 114 mL) (P < 0.0001, P < 0.01, and P < 0.05, respectively). The NaP regimen also showed a higher residual volume (165 ± 135 mL) than OSS but without quite reaching a statistically significant difference (P = 0.067) (Fig. 4A) . Residual fluid volumes <200 mL were recorded less frequently with the individual established agents, in 55.0% (27/60 examinations, P < 0.01) with 29 NaP, 68.3% (41/60 examinations, P = 0.1) with MgC, 68.3% (41/60 examinations, P = 0.1) with PEG, 73.3% (44/60 examinations, P = 0.2) with NaP than as shows mean residual colonic fluid volume. The fluid volume was significantly lower for OSS regimen (125 ± 60 mL) than for established cathartic agents (average of 29 NaP, MgC, NaP, and PEG) (180 ± 121 mL) (P < 0.001). Note the outliers (dots) and extreme outliers (triangles) with high fluid volumes of up to 853 mL when using established cathartic agents, which hamper 3D endoluminal fly-through without electronic cleansing. Dotted line indicates 200 mL threshold of total residual colonic fluid. B Bar graph shows the mean attenuation of the residual colonic fluid. The attenuation was significantly higher for the OSS regimen (956 ± 167 HU) as compared to the average of established cathartic agents (692 ± 223 HU) (P < 0.0001).
compared to OSS regime with 87% (20/23 examinations). All individual established regimens (29 NaP, MgC, NaP, and PEG) showed a significant higher variance of residual fluid volume than the novel OSS regime (all P < 0.01).
The attenuation of the residual fluid for all of the individual established cathartic agents was significantly lower than of OSS regimen. Mean attenuation of colonic fluid for 29 NaP, MgC, NaP, and PEG was 455 ± 191, Fig. 3 . CTC examinations in two patients receiving the new OSS regimen (A) and the established sodium phosphate regimen (B). A Axial two-dimensional CTC image from a 62-year-old man who underwent OSS regimen illustrates the calculated low total residual fluid volume (89 mL) with high attenuation (897 HU). B Axial two-dimensional CTC image from a 58-year-old man who underwent sodium phosphate regimen illustrates the calculated high residual total fluid volume (853 mL) with low attenuation (440 HU). Note the good conspicuity of colonic fold against the high attenuation fluid after OSS regimen (A arrow head) as compared to poor conspicuity of a fold against the low attenuation fluid after MgC regimen (B arrowhead). Both cases also illustrate the inadequacy of the established manual fluid volume and attenuation quantification methods. In A, the volume of descending colon occupied by fluid would be rated >50%, albeit this is not due to high fluid volume, but rather due to poor overall distension. In B, the different attenuations of the fluid within the colon are clearly evident and indicate the sampling error of manual ROI-based methods for attenuation quantification. Fig. 4 . Mean volume and attenuation of residual colonic fluid for each cathartic agent as quantified by automated volumetric QA tool. A Box and whisker plots showing mean residual colonic fluid volume. The mean residual volume was smallest when using the OSS regimen (125 ± 60 mL) and significantly higher when using 29 NaP regimen (206 ± 125 mL) (P < 0.0001), MgC regimen (184 ± 125 mL) (P < 0.01), and PEG regimen (166 ± 114 mL) (P < 0.05). NaP regimen showed also a higher residual volume (165 ± 135 mL) than OSS regimen but without reaching a statistically difference (P = 0.067). Note the outliers with high residual volumes with established cathartic agents that are not observed with OSS. Dotted line indicates 200 mL threshold of total residual colonic fluid. B Box and whisker plots showing the mean attenuation of the residual colonic fluid. The attenuation was significantly higher for the OSS regimen (955 ± 167 HU) as compared to all of the other established cathartic agents, ranging from 406 ± 191 HU for 29 NaP regimen (P < 0.0001) to 843 ± 193 HU for PEG regimen (P = 0.012).
691 ± 154, 779 ± 127, and 843 ± 193 HU, respectively (P < 0.0001, P < 0.0001, P < 0.0001, and P = 0.012, respectively) (Fig. 3B) . The volume of the residual colonic fluid was negatively correlated with fluid attenuation values: r = -0.262 (P < 0.0001) across all the different cathartic regimens. As residual fluid volume decreases, the degree of fluid attenuation generally increases. The correlation is plotted in Fig. 5 .
Discussion
With the use of an automated QA software tool that rapidly and objectively determines the volume and attenuation of residual colonic fluid at CTC, we have shown that bowel preparation using the novel OSS (SUPREP) regimen is superior to the previously established cathartic agents. The OSS regimen resulted in less residual colonic fluid compared with previous standard regimens using MgC, NaP, and PEG. In addition, the variance of the residual volume was also significantly lower with the OSS regimen, suggesting a more consistent result. Use of the automated QA software also revealed that as residual fluid volume decreases, the degree of fluid attenuation generally increases.
Minimization of residual luminal fluid produces higher examination quality and therefore likely improves the ability to correctly identify colorectal lesions at CTC [15, 20] . This is especially the case when electronic cleansing (digital subtraction) is not employed in order to avoid the often-disturbing artifacts [25, 26] . Because only the gas-filled portions of the colon can be evaluated at 3D endoluminal fly-through without electronic cleansing, the amount of residual fluid directly correlates with lesion detection, as evaluation of fluid-filled regions are limited to 2D assessment. In our study the residual volume in the group receiving the OSS regimen (125 mL) was significantly lower (32% less fluid) than our current default cathartic agent MgC (184 mL). Whether this statistically significant difference of 59 mL is also clinically relevant would be best evaluated in future prospective studies that also address the rate of polyp detection. We also found only slightly higher residual total volume (10% more fluid) in the group receiving MgC (184 mL) as compared to the group receiving the formerly widely used agent NaP (165 mL). This is in line with a recent study by Borden et al. [19] , who found no significant difference of residual fluid volume between the groups receiving MgC and NaP regime using a semiquantitative four-point scale.
The attenuation of the residual fluid in the group receiving OSS regimen (955 HU) was significantly higher (28% higher attenuation) as compared with MgC (691 HU). Our finding that the currently recommended MgC regimen leads to a lower residual fluid attenuation of 691 HU as compared with NaP (779 HU) are also in line with the study by Borden et al. [19] , who reported a significantly higher fluid attenuation of 978 HU for NaP compared with 790 HU for MgC. The offset between the two studies of~200 HU for MgC and of~100 HU for NaP is likely due to the fact that Borden et al. randomly sampled the attenuation of fluid only in the ascending and descending colon. In contrast, our automated QA software calculated the average attenuation of the total fluid within all colonic segments.
The optimal attenuation of tagged residual fluid for optimal polyp conspicuity depends on the viewing window used for CTC reading as shown in an experimental setting by Slater et al. [27] . Slater et al. recommended changing the window settings contingent on the attenuation value of tagged fluid when one reviews submerged areas to ensure that no polyp is missed. The QA software tool in our study could be further developed and linked with the two-dimensional viewing console for automated setting of the optimal viewing window according to average residual fluid attenuation. Using a viewing window adjusted to attenuation of residual fluid will maximize both detection and measurement accuracy of submerged polyps.
The automated volumetric assessment matches well with previous studies based on semi-quantitative assessment of residual fluid volume and attenuation. However, prior subjective reader volume scores and attenuation measurements are considerably more labor intensive [16, 19, 20] . Moreover, using subjective methods that score the percentage of the colonic lumen filled with fluid are prone to error because these scores are highly dependent on the degree of gaseous distension, which can dramatically affect these semi-quantitative readings. There have been previous efforts to provide automated assessment of colonic distention and/or residual fluid at CTC [28] [29] [30] . However, those attempts have provided primarily linear diameter assessment in defined colonic segments and not a true volumetric analysis of the entire colon. Similar to the above-mentioned subjective reading studies, residual fluid was determined by the percentage of colonic surface area covered by fluid, a value that is highly dependent on the overall colonic distension. Using the fully automated volume QA software tool from this study provides data of the total residual colonic fluid volume that is independent of distention. These data are therefore more objective, more robust, less error prone, and also amplify true differences compared with random samples and/or linear measures. Residual fluid volumes <200 mL were recorded in 66.3% of patients following the use of established agents and in 87.0% following OSS regime. The results did not quite reach statistical significance (P = 0.06), however, this is attributed to the smaller cohort of patients with OSS regimen (n = 23).
Our results using a single bottle of SUPREP extend the findings of a recent OC study where a double-bottle split-dose regimen of OSS provided superior CTC bowel cleansing compared with a standard regimen [23] . The reason for our excellent results using only a single bottle of OSS is likely due to the additional cleansing provided by the ionic-iodinated oral contrast (sodium diatrizoate/ diatrizoate meglumine). Using a single bottle of lowvolume OSS taken the evening before CTC increases the safety, reduces the costs and will likely increase patient acceptance and compliance. Our findings suggest that SUPREP purgation with oral contrast cleansing may improve the diagnostic performance for CTC by reducing the volume of residual fluid.
To put our findings into a clinical context, our results support the use of automated QA software tools for quality assessment of CTC. Utilization of such automated software provides useful quality assurance data and may be employed to improve bowel preparation at individual screening sites. The QA software could be used as part of a quality control program to warn of a slow downward drift in examination quality over time and to indicate the need for additional patient education regarding bowel preparation. Moreover, the presented QA software would enable comparison of data sets from different institutions and from different validation trials. This would ensure a level of uniformity and point out deficiencies of a given program.
We acknowledge limitations to our study. We did not assess the effect of fluid volume and attenuation on lesion detection, but this has been repeatedly shown in larger CTC trials. The automated QA software does not provide segmental data and cannot identify and pinpoint areas that are submerged with fluid. Rather, it rapidly and objectively provides total colonic residual fluid volume and attenuation data as an overall assessment. We did not directly compare our automated method with subjective reading of residual fluid volume and attenuation, because these methods are prone to error as discussed above. It is an inherent limitation of the presented QA software that it does not allow for scoring of residual adherent tagged solid stool-separate from the fluid pools. The amount of residual adherent solid stool is another important factor in assessing the fidelity of bowel preparation at CTC, since its presence complicates polyp detection [26, 31, 32] . The QA software tool will have to be developed further and adapted for assessment of residual stool.
In summary, we have found that the automated QA software tool employed in this study provides an objective quality assessment of bowel preparation at CTC, allowing for rapid and reliable comparison between different regimens. Using automated QA software that objectively determines volume and attenuation of residual colonic fluid at CTC revealed that bowel preparation using the novel OSS regimen (SUPREP) is superior to the previously established regimens. Given the low residual volume, OSS is an excellent alternative for bowel preparation and may lead to improved polyp detection.
